← back to search

Jennifer Scalici

Emory University · US
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cervical Cancer and HPV Research, and Cancer Immunotherapy and Biomarkers.
h-index
23
citations
2,422
works
147
NIH funding
primary concept
email

Recent publications

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer
Gynecologic Oncology 2025cited by 10position: middledoi
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
International Journal of Gynecological Cancer 2023cited by 28position: middledoi
The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes
Gynecologic Oncology 2022cited by 33position: middledoi
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer
Journal of Ovarian Research 2022cited by 19position: middledoi
The novel NSAID-derivative, MCI-030, prevents ovarian cancer in the egg-laying hen by increasing tumor cell apoptosis and decreasing beta-catenin and MAPK oncogenic signaling
Gynecologic Oncology 2021cited by 0position: lastdoi
Exploring the role of PDE10 inhibition in ovarian cancer carcinogenesis in the egg-laying hen using RNA sequencing
Gynecologic Oncology 2021cited by 0position: lastdoi
A novel NSAID derivative for ovarian cancer chemoprevention in the hen model
Gynecologic Oncology 2019cited by 0position: lastdoi
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
The Lancet Oncology 2017cited by 897position: middledoi
Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
Gynecologic Oncology 2017cited by 32position: middledoi
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
PLoS ONE 2014cited by 169position: middledoi
Validation of a venous thromboembolism risk assessment model in gynecologic oncology
Gynecologic Oncology 2014cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2014–2022)Gary A. Piazza · Auburn University4 papers (2019–2022)Rodney P. Rocconi · University of Mississippi Medical Center3 papers (2014–2017)Michael A. Finan · University of South Florida2 papers (2014–2014) · 2 papers (2014–2014)Wallace D. Berry · Auburn University2 papers (2021–2021)Annelise Wilhite · Carilion Clinic2 papers (2021–2022) · 2 papers (2021–2022)Rebecca Barber · Princeton University2 papers (2021–2021) · 2 papers (2021–2022)Kevin Schuler · University of Virginia1 papers (2017–2017)Debra L. Richardson · Southwestern Medical Center1 papers (2025–2025)Xi Chen · The First Affiliated Hospital, Sun Yat-sen University1 papers (2021–2021)Xi Chen · Second People's Hospital of Yunnan Province1 papers (2022–2022) · 1 papers (2014–2014)Rabbie K. Hanna · University of Virginia1 papers (2017–2017)Kellie E. Schneider · University of Alabama at Birmingham1 papers (2014–2014)Maria C. Bell · Indiana University School of Medicine1 papers (2025–2025)Lee‐Jen Wei · Palo Alto University1 papers (2025–2025)Steve McClellan · University of Florida1 papers (2014–2014)